Universal testing for MSI/MMR status in colorectal and endometrial cancers to identify Lynch syndrome cases: state of the art in Italy and consensus recommendations from the Italian Association for the Study of Familial Gastrointestinal Tumors (A.I.F.E.G.)

Affiliations

¹ UO Anatomia Patologica Ospedale di Circolo ASST-Settelaghi Varese.
² Centro di ricerca per lo studio dei tumori eredo-familiari, Università dell'Insubria Varese, Varese.
³ Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo.
⁴ Unit of Functional Oncogenomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Via F. Gallini 2, Aviano.
⁵ Institute of Genomic Medicine, Catholic University, Rome.
⁶ Pathology Unit, ULSS9 "Scaligera", Via Valverde, Verona.
⁷ Clinica Chirurgica 1, Dip di Scienze Oncologiche e Chirurgiche, Azienda Ospedaliera Università di Padova, Padova.
⁸ Ambulatorio Familiarita' Neoplastica UOC Oncologia medica ULSS5 Polesana, Rovigo.
⁹ Department of Biology and Biotechnology, Via Ferrata 9, University of Pavia, Pavia, Italy.

Maria Grazia Tibiletti et al. Eur J Cancer Prev. 2022.

. 2022 Jan 1;31(1):44-49.

doi: 10.1097/CEJ.0000000000000677.

¹ UO Anatomia Patologica Ospedale di Circolo ASST-Settelaghi Varese.
² Centro di ricerca per lo studio dei tumori eredo-familiari, Università dell'Insubria Varese, Varese.
³ Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo.
⁴ Unit of Functional Oncogenomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Via F. Gallini 2, Aviano.
⁵ Institute of Genomic Medicine, Catholic University, Rome.
⁶ Pathology Unit, ULSS9 "Scaligera", Via Valverde, Verona.
⁷ Clinica Chirurgica 1, Dip di Scienze Oncologiche e Chirurgiche, Azienda Ospedaliera Università di Padova, Padova.
⁸ Ambulatorio Familiarita' Neoplastica UOC Oncologia medica ULSS5 Polesana, Rovigo.
⁹ Department of Biology and Biotechnology, Via Ferrata 9, University of Pavia, Pavia, Italy.

No abstract available

References

1. Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, et al. (BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 2012). 30:2654–2663.
1. Anon (Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009). 11:35–41.
1. Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN (Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer 2005). 4:255–265.
1. Chiaravalli AM, Carnevali I, Sahnane N, Leoni E, Furlan D, Berselli M, et al. (Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center. Eur J Cancer Prev 2020). 29:281–288.
1. Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, et alManchester International Consensus Group. (The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 2019). 21:2390–2400.